S/N | Study design | No. of subjects (Nation) | Sampling for serum 25(OH)D (Trimester/Weeks) | Cut off value for 25(OH)D deficiency/ insufficiency | Results(Maternal vitamin D level vs. incidence of GDM) | Reference | |
1 | Cross sectional | 886 (Spain) | Second trimester | <20 ng/mL | Vitamin D deficiency is associated with GDM, independent of BMI. | [26] | |
2 | Cross sectional | 80 (Turkey) | Second trimester | 10 - 20 ng/mL | Serum vitamin D levels in women with GDM are significantly lower than the controls. | [27] | |
3 | Cross sectional | 90 (Iran) | 20 - 30 weeks | 10 - 20 ng/ml | Serum 25(OH)D level is significantly low in GDM group. | [28] | |
4 | Cross sectional | 78 (Malaysia) | Third trimester | <12 ng/ml | Women with GDM had lower vitamin D status which was associated with ethnicity and less outdoor activity. | [29] | |
5 | Cross sectional | 228 (Philippine) | Second & third trimesters | ≤20 ng/ml. | An association found between low level of (≤30 ng/ml) maternal serum vitamin D level and GDM (OR = 0.28; 95% CI = 0.09 - 0.88) but none was evident after adjusting for possible confounders (OR = 0.66; 95% CI = 0.18 - 2.36). | [30] | |
6 | Cross sectional | 723 (Finland) | 11 weeks | <50 nmol/L | No association found. | [58] | |
7 | Cross sectional | 1400 (Turkey) | 24 - 28 weeks | <20 ng/mL (Severe deficiency) | No association found. | [59] | |
8 | Cross sectional | 80 (Iran) | 24 - 28 weeks | <20 ng/dL | No association found. | [60] | |
9 | Prospective cohort | 1314 (USA) | 26 - 28 | 25 - 50 nmol/L | Pregnant mothers with 25(OH)D levels of 25 nmol/L may have higher odds of experiencing GDM (OR: 2.2, 95% CI: 0.8 - 5.5). | [31] | |
10 | Prospective cohort | 515 (Saudi) | First trimester | <50 nmol/L | GDM risk was significantly higher among vitamin D deficient group (OR: 2.87; Confidence Interval: 1.32 - 6.25; P = 0.008 | [32] | |
11 | Prospective cohort | 655 (Canada) | 06 - 13 | <50 nmol/L | Lower first trimester 25(OH)D level is associated with higher risk of developing GDM (OR = 1.48; 95% CI = 1.03 - 2.12), and higher HOMA-IR (r = −0.08; P = 0.03). | [33] | |
12 | Prospective cohort | 392 (South India) | 12 weeks | <50 nmol/L | Vitamin D deficiency in early pregnancy is significantly associated with developing GDM. | [34] | |
13 | Prospective cohort | 890 (Australia) | 18 weeks | <30 nmol/L | Second trimester low maternal 25(OH) D levels (<30 nmol/L) are associated with GDM (OR = 14.63, 95% CI = 1.59 - 134.78). | [35] | |
14 | Prospective cohort | 2800 (Australia & New Zealand) | 15 ± 1 weeks | <50 nmol/L | GDM risk was observed with high (>81 nmol/L) “standardised” vitamin D status when compared to moderate-high (63 - 81 nmol/L) | [36] | |
15 | Prospective cohort | 64 (Turkey) | 24 - 28 | <10 ng/l (Severe deficiency) | 25(OH)D levels were negatively correlated with HOMA-IR (P < 0.001). | [37] | |
16 | Prospective cohort | 3318 (China) | 8 - 14 weeks | <20 ng/ml | Vitamin D deficiency in T2 was associated with an increased risk of GDM with increased FBG of OGTT. | [38] | |
17 | Prospective cohort | 674 (USA) | <16 | <50 nmol/L | There was a negative association between 25(OH)D and maternal hyperglycaemia among smokers (OR = 0.30; 95% CI = 0.13 - 0.68) while no association found among non-smokers. | [39] | |
18 | Prospective cohort | 1710 (New Zealand) | 15 | <50 nmol/l | No association found. | [40] | |
19 | Prospective cohort | 523 (Korea) | 24 - 28 20 - 22 32 - 34 | <25 nmol/L | No association found. | [61] | |
20 | Prospective cohort | 80 (Egypt) | 24 - 28 | <20 ng/mL | No association found. | [62] | |
21 | Prospective cohort | 785 (Australia) | 6 - 14 & 14 - 18 | <12.5 nmol/L (Severe deficiency) | No association found. | [63] | |
22 | Prospective cohort | 524 (Canada) | 17 - 18 | <50 nmol/L | No association found. | [64] | |
23 | Prospective cohort | 785 (Norway) | 15 - 28 weeks | <50 nmol/L | No association found. | [65] | |
24 | Prospective cohort | 3110 (China) | First trimester | <20 ng/ml | No association found. | [66] | |
25 | Prospective cohort | 938 (Iceland) | 11 - 14 weeks | <30 nmol/L | No association found. | [67] | |
26 | Prospective cohort | 1516 (China) | 11 - 14 weeks | <50 nmol/L | No association found. | [68] | |
27 | Retrospective cohort | 8468 (China) | <20 weeks | <20 ng/ml | Vitamin D level > 20 ng/mL can reduce the risk of GDM (OR = 0.90). | [41] | |
28 | Retrospective cohort | 2814 (China) | ≤20 weeks | <50 nmol/L | A protective association was found between higher serum 25(OH)D concentrations and GDM (P = 0.003). | [42] | |
29 | Retrospective cohort | 7816 (China) | 6 - 14 weeks | <20 ng/ml | No association found. | [69] | |
30 | Retrospective cohort | 235 (USA) | 5 - 12 weeks | <20 ng/ml | No association found. | [70] | |
31 | Nested case control | 400 (China) | 26 - 28 | <25 nmol/L | Subjects with 25(OH)D deficiency had 1.8-fold higher risk of GDM (OR: 1.800, 95% CI: 1.209 - 2.678, P = 0.004). | [43] | |
32 | Nested case control | 210 (India) | <20 | <20 ng/mL | Women with vitamin D deficiency in early pregnancy were eleven times more likely to have GDM compared to controls (P = 0.001) | [44] | |
33 | Nested case control | 335 (Canada) | 15 - 18 | <75 nmol/l (Insufficient) | Vitamin D insufficiency in early pregnancy is associated with a greater than twofold increase in subsequent gestational diabetes, even after matching and adjusting for race, age, season and weight. | [45] | |
34 | Nested case control | 321 (USA) | 10 - 14 23 - 31 33 - 39 | <50 nmol/L. | Women with persistent vitamin D deficiency at 10 - 14 and 15 - 26 weeks of gestation had a 4.46-fold elevated risk for GDM. | [46] | |
35 | Nested case control | 2320 (Canada) | <20 weeks | <30 nmol/L | In smokers, significant increased odds of developing GDM was seen among women with 25(OH)D < 30 nmol/L [aOR = 3.73, 95% CI 1.9, 7.14] compared to non-smokers with 25(OH)D concentration ≥50 nmol/L. | [47] | |
36 | Nested case control | 652 (USA) | 16 | <20 ng/mL or <50 nmol/L | No association found. | [48] | |
37 | Nested case control | 180 (USA) | 11 - 14 | <50 nmol/L. | No association found. | [71] | |
38 | Nested case control | 1191 (Belgium & France) | 11 - 15 | <10 ng/mL (deficiency) <20 ng/mL (insufficiency) | No association found. | [72] | |
39 | Nested case control | 318 (Russia) | 8 - 14 & 24 - 32 | <20 ng/mL | No association found. | [73] | |
40 | Nested case control | 5109 (Australia) | First trimester | <25 nmol/L | No association found. | [74] | |
41 | Case control | 120 (Turkey) | 26 - 28 | <25 ng/mL | Vitamin D deficiency in the second trimester was inversely correlated with fasting and 1-h plasma glucose after 75 g glucose challenge test (P < 0.001), also low 25 OHD3 levels were associated with insulin resistance. | [49] | |
42 | Case control | 60 (Korea) | Third trimester | <20 ng/mL | Serum levels of 25(OH)D were lower in women with GDM (P < 0.01). | [50] | |
43 | Case control | 70 (India) | <28 weeks | <20 ng/ml | Vitamin D deficiency is more frequently associated with GDM than the controls. | [51] | |
44 | Case control | 80 (Egypt) | <28 weeks | <10 ng/ml | Serum 25 (OH)D had a significant negative correlation with fasting insulin level (P = 0.05). | [52] | |
45 | Case control | 40 (Turkey) | 24 - 28 | <10 ng/mL | No association found. | [75] | |
46 | Case control | 157 (Brazil) | Third trimester | <10 ng/ml | No association found. | [76] | |
47 | Case control | 76 (Central Europe) | 24 - 30 weeks | <50 nmol/L | No association found. | [77] | |
48 | Case control | 122 (Istanbul) | 24 - 28 | ≤20 ng/ml | No association found. | [78] | |